The Conduct of Clinical Trials for Medicinal Products in Europe in the Light of the European Clinical Trials Directive. Review of Regulatory and Practical Aspects in the Different Countries
Therapie
.
2007 May-Jun;62(3):199-202.
doi: 10.2515/therapie:2007047.
Authors
Claude Dubray
1
,
Patricia Maillere
2
,
Alain Spriet
3
;
participants in Round Table N° 1, Giens XXII
Collaborators
participants in Round Table N° 1, Giens XXII
:
Michel Abitboul
,
Béatrice Barraud
,
Marie Castera-Tellier
,
François Chapuis
,
François Faurisson
,
Elizabeth Frija-Orvoen
,
Jean Genève
,
Anne-Sophie Ginon
,
Corinne Guérin
,
Thierry Herguetta
,
Denis Lacombe
,
Véronique Lamarque
,
Christian Libersa
,
Brigitte Marchenay
,
Christine Marey
,
Annie Métro
,
Armelle Mijonnet
,
Claire Orefice
,
Gérard Pons
,
Nathalie Quideau
,
Isabelle Richard-Lordereau
,
Christian Rollin
,
Elisabeth Rouffiac
,
Philippe Rusch
,
Claire Sibenaler
,
Sandra Touratier
Affiliations
1
Pharmacologie Clinique, CHU Clermont Ferrand, Clermont Ferrand, France.
2
IRIS, Groupe Servier, Courbevoie, France. Electronic address: maillere@fr.netgrs.com.
3
Spriet Conseil, Paris, France.
PMID:
27393402
DOI:
10.2515/therapie:2007047
No abstract available
Keywords:
Afssaps; clinical trial; ethics committee; pharmacovigilance.